KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Current Deferred Revenue (2016 - 2021)

Historic Current Deferred Revenue for CareDx (CDNA) over the last 9 years, with Q4 2021 value amounting to $4.2 million.

  • CareDx's Current Deferred Revenue rose 1920.68% to $4.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.2 million, marking a year-over-year increase of 1920.68%. This contributed to the annual value of $4.2 million for FY2021, which is 1920.68% up from last year.
  • Per CareDx's latest filing, its Current Deferred Revenue stood at $4.2 million for Q4 2021, which was up 1920.68% from $3.4 million recorded in Q3 2021.
  • In the past 5 years, CareDx's Current Deferred Revenue ranged from a high of $4.2 million in Q4 2021 and a low of $39000.0 during Q4 2018
  • Its 5-year average for Current Deferred Revenue is $2.0 million, with a median of $1.8 million in 2018.
  • As far as peak fluctuations go, CareDx's Current Deferred Revenue crashed by 9069.21% in 2018, and later skyrocketed by 935128.21% in 2019.
  • CareDx's Current Deferred Revenue (Quarter) stood at $419000.0 in 2017, then tumbled by 90.69% to $39000.0 in 2018, then surged by 9351.28% to $3.7 million in 2019, then fell by 4.23% to $3.5 million in 2020, then increased by 19.21% to $4.2 million in 2021.
  • Its Current Deferred Revenue was $4.2 million in Q4 2021, compared to $3.4 million in Q3 2021 and $3.9 million in Q2 2021.